ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	12 December 2020
Main ID:	NCT03775824
Date of registration:	11/12/2018
Prospective Registration:	No
Primary sponsor:	Region Skane
Public title:	Faecal Analyses in Rheumatoid Arthritis Therapy FART
Scientific title:	Faecal Analyses in Rheumatoid Arthritis Therapy: An Prospective Observational Study of the Intestinal Microbiome in Patients With Rheumatoid Arthritis Receiving Immunosuppressive Therapy
Date of first enrolment:	August 1, 2016
Target sample size:	50
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT03775824
Study type:	Observational
Study design:
Phase:

Countries of recruitment

Contacts

Name:	Kristofer Andréasson, MD PhD
Address:
Telephone:
Email:
Affiliation:	Skane University Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- Rheumatoid arthritis according to the 2010 classification criteria

- About to start methotrexate or TNF-inhibitor because of active disease

Exclusion Criteria:

- Failure to understand protocol

- A history of alcohol abuse

- Concomitant inflammatory bowel disease

- Any history of diverticulitis

- A history of failure to comply with prescribed medication

- Ongoing biological therapy

Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Rheumatoid Arthritis

Intervention(s)

Drug: MTX start

Drug: TNF start

Primary Outcome(s)

Change in disease activity/treatment response at follow up [Time Frame: Change from baseline DAS-28 at 6 months]

Intestinal gut flora in rheumatoid arthritis [Time Frame: Analysis made at study start/baseline]

Change in gut flora [Time Frame: Change from baseline Dysbiosis Index Score at 6 months]

Secondary Outcome(s)

Adherance to immunosuppressive therapy [Time Frame: Analysis made at 6 months follow up]

Change in intestinal concentration Lactobacillus [Time Frame: Change from baseline concentration at 6 months]

Change in intestinal concentration Prevotella [Time Frame: Change from baseline concentration at 6 months]

Change in intestinal concentration Clostridia [Time Frame: Change from baseline concentration at 6 months]

Secondary ID(s)

FART1

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.